Category: Pediatric NASH

All Podcast Categories
S4-40 - Review of Paris NASH 2023

S4-40 – Review of Paris NASH 2023

Surfing NASH returns to its regular podcast schedule with a review of the recently concluded Paris NASH meeting. Presenters and KOLs Scott Friedman and Laurent Castera join Jörn Schattenberg, Louise Campbell and Roger Green for an exciting episode that focuses largely on important and emerging questions surrounding the use of NITs in a landscape which features drug approval. Surf on to learn much more from what always pans out to be an incredibly in-depth and insightful event.

S4-28 - Tetiana Deshko on the public health care in Ukraine during the invasion

S4-28 – Tetiana Deshko on the public health care in Ukraine during the invasion

For the first time, Surfing NASH will not be discussing liver disease on the podcast. Instead, Roger Green and Michael Betel host an exclusive interview with Tetiana Deshko, Director of Programs for the Alliance for Public Health in Ukraine. Dr Deshko shares her moving story of the challenges of providing health for patients in the midst of an invasion and the challenges public health advocates face in caring for these patients on the frontlines of a war.

S4-26.3 - FibroScan and the Impact of Socioeconomic Factors on Liver Health

S4-26.3 – FibroScan and the Impact of Socioeconomic Factors on Liver Health

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation offers observations around the new NICE guidance that supports FibroScan use in primary care settings. The group ventures on to discuss the effects of socioeconomic status on access to improved liver health.

S4-26.2 - the Rise of NAFLD/NASH in Adolescents

S4-26.2 – The Rise of NAFLD/NASH in Adolescents

The podcast celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. This conversation focuses on the increasing incidence of NAFLD/NASH among adolescents. The group explores ideas around why this is happening and what to do about it.

S4-25.2 - NICE Guidance for FibroScan: Collecting Data Well and Wisely

S4-25.2 – NICE Guidance for FibroScan: Collecting Data Well and Wisely

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation speculates on the value and accuracy of FAST and other tests. The group considers the importance of collecting data and what impact the guidance and experience in the UK will have for onlooking systems.

S4-E25.1 - Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

S4-E25.1 – Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan

William Alazawi and Vanessa Hebditch join Louise Campbell and Roger Green to celebrate and comment on evidence-based guidance from NICE on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care in the UK. This conversation focuses on the role of the British Liver Trust in this process and the importance of data collection for quality assurance.